August 6, 2015
New targeted therapy shows promise for rare joint tumor
Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities.
By VUMC News and Communications